The researchers found a higher proportion of MAP4 to stathmin mRNA in NSCLC tissues than the above proportion in normal specimens, demonstrating that this proportion might be a potential prognostic marker in NSCLC patients (42). The gene discussed is STMN1; the disease is non-small cell lung carcinoma.